Lates News

GlaxoSmithKline: AnaptysBio seeks to revoke Tesaro's license for dostarlimab. Both GlaxoSmithKline and Tesaro are firm in our belief that the allegations are completely unfounded, and we will continue to focus on advancing this claim in court.